A detailed history of Harvest Fund Management Co., LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 17,707 shares of MRNA stock, worth $652,502. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,707
Previous 12,163 45.58%
Holding current value
$652,502
Previous $1.44 Million 18.07%
% of portfolio
0.07%
Previous 0.11%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$63.64 - $125.14 $352,820 - $693,776
5,544 Added 45.58%
17,707 $1.18 Million
Q2 2024

Aug 08, 2024

SELL
$101.21 - $166.61 $13,562 - $22,325
-134 Reduced 1.09%
12,163 $1.44 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $760,646 - $1.03 Million
8,910 Added 263.06%
12,297 $1.31 Million
Q4 2023

Feb 01, 2024

BUY
$69.51 - $104.43 $24,745 - $37,177
356 Added 11.75%
3,387 $336,000
Q3 2023

Nov 06, 2023

BUY
$96.41 - $126.61 $108,268 - $142,183
1,123 Added 58.86%
3,031 $313,000
Q2 2023

Jul 07, 2023

BUY
$118.5 - $160.53 $102,028 - $138,216
861 Added 82.23%
1,908 $232,000
Q1 2023

May 10, 2023

SELL
$135.66 - $197.02 $142,714 - $207,265
-1,052 Reduced 50.12%
1,047 $161,000
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $143,358 - $254,358
1,211 Added 136.37%
2,099 $373,000
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $76,037 - $125,051
-644 Reduced 42.04%
888 $105,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $33,499 - $50,504
-286 Reduced 15.73%
1,532 $219,000
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $110,020 - $204,493
-870 Reduced 32.37%
1,818 $313,000
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $151,751 - $247,638
-672 Reduced 20.0%
2,688 $673,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $132,252 - $288,744
596 Added 21.56%
3,360 $1.29 Million
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $27,540 - $49,815
212 Added 8.31%
2,764 $649,000
Q1 2021

May 13, 2021

SELL
$109.18 - $185.98 $35,374 - $60,257
-324 Reduced 11.27%
2,552 $334,000
Q4 2020

Feb 10, 2021

BUY
$65.74 - $169.86 $5,916 - $15,287
90 Added 3.23%
2,876 $300,000
Q3 2020

Nov 04, 2020

BUY
$54.34 - $94.85 $48,960 - $85,459
901 Added 47.8%
2,786 $200,000
Q2 2020

Aug 12, 2020

SELL
$29.67 - $80.0 $44,326 - $119,520
-1,494 Reduced 44.21%
1,885 $116,000
Q1 2020

May 08, 2020

BUY
$17.78 - $31.58 $60,078 - $106,708
3,379 New
3,379 $95,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.